Smartphone quit-smoking program for American Indian and Alaska Native adults
Official title: Digital smoking cessation intervention for nationally-recruited American Indians and Alaska Natives: A full-scale randomized controlled trial
Funded at Fred Hutchinson Cancer Center · NIH-11170566 · Data updated 2026-11-12
This project tests a smartphone app based on Acceptance and Commitment Therapy to help American Indian and Alaska Native adults quit smoking compared with the NCI QuitGuide app.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | September 20, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $2,116,867 |
| NIH project number | 4R01CA284687-03 |
| Project ID | NIH-11170566 on NIH RePORTER |
Who could benefit from this research
✓Could help
American Indian or Alaska Native adults aged 21 or older who currently smoke and want help quitting are the ideal candidates.
✕Less likely to help
People who do not use smartphones, are younger than 21, or prefer non-digital cessation methods may not receive benefit from this app-based approach.
What this research studies
I would be randomly assigned to use either the iCanQuit app (an Acceptance and Commitment Therapy-based program) or the NCI QuitGuide app and follow the program on my own phone. The trial recruits American Indian and Alaska Native adults across the United States and collects regular follow-up information on smoking and abstinence. The team aims to reach people in remote areas with limited access to quitting services and provide a low-cost, widely available quitting tool. The work builds on earlier promising results for iCanQuit among AIAN participants.
Why it matters
Potential benefit: If successful, the app could help AIAN adults quit smoking by delivering accessible, culturally relevant support and reduce smoking-related illness.
How similar studies have gone: Preliminary data showed promising quit signals for the iCanQuit app among AIAN participants, but very few full-scale randomized trials have focused on this population.
Where this research is happening
-
Fred Hutchinson Cancer Center
Seattle, United States Active
Researchers
- Principal investigator: Bricker, Jonathan B — Fred Hutchinson Cancer Center
- Study coordinator: Bricker, Jonathan B
Related research
Other NIH-funded projects on the same topics.
-
Using exenatide with nicotine patches to help people quit smoking and manage weight gain.
This study is looking at how well using exenatide, a medication that helps with appetite and blood sugar, along with nicotine patches can help people quit smoking while also managing weight gain that often happens after quitting.
-
A new app to help people with serious mental illness quit smoking.
This study is testing a friendly mobile app called Learn to Quit, which helps people with serious mental illnesses like schizophrenia and bipolar disorder to stop smoking by using helpful techniques and support.
-
A digital app to help American Indians and Alaska Natives quit smoking
This study is testing a smartphone app that helps American Indians and Alaska Natives quit smoking by offering support and resources based on proven techniques, and it's designed to make it easier for them to overcome challenges in stopping smoking.
-
Social stress and smoking: why disadvantaged young adults struggle to quit
This grant looks at how daily social stress affects if and when disadvantaged young adults who smoke can quit and stay quit.
-
I-STOP: a mobile health program to help people with HIV quit smoking
A smartphone-based program designed to help people with HIV quit smoking in a sustainable, affordable way.
-
Smoking cessation help for people with HIV in South Africa
A program is being tested to help people living with HIV in South Africa quit smoking in ways that fit low-resource clinics and show good value.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.